Frank Dipalma
Foot & Ankle Surgery · Athens, GANPI 1982602561
Payments from drug & device makers
Across 26 payments — averaging $33.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$352
- Organogenesis Inc.$136
- Triad Life Sciences Inc.$74
- Averitas Pharma Inc.$66
- Johnson & Johnson$41
- Paragon 28, Inc.$31
- plus $164 from 9 others
What the payments were for
- Food & beverage$863100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 4 | $352 |
| Organogenesis Inc. | 5 | $136 |
| Triad Life Sciences Inc. | 1 | $74 |
| Averitas Pharma Inc. | 3 | $66 |
| Johnson & Johnson | 2 | $41 |
| Paragon 28, Inc. | 1 | $31 |
| Reprise Biomedical, Inc. | 2 | $27 |
| Osteomed LLC | 1 | $24 |
| Zimmer Biomet | 1 | $20 |
| Surgenex LLC | 1 | $19 |
| Stryker | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Arteriocyte Medical Systems, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$863 in reported general payments places this provider in the 25th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 128 | $3,589 |
| Mupirocin | 334 | $2,400 |
| Doxycycline Hyclate | 205 | $2,007 |
| Clobetasol Propionate | 24 | $1,154 |
| Lidocaine | 12 | $1,136 |
| Diclofenac Sodium | 13 | $912 |
| Ketoconazole | 39 | $884 |
| Ammonium Lactate | 28 | $736 |
| Gabapentin | 84 | $506 |
| Duloxetine Hcl | 38 | $478 |
| Pentoxifylline | 13 | $428 |
| Doxycycline Monohydrate | 31 | $318 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $233 |
| Terbinafine Hcl | 22 | $201 |
| Ropinirole Hcl | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Athens
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$229K
- Scott RomanPeachtree City$118K
- Jeffrey FlashForest Park$114K
- Mickey StappThomson$110K
- David MurphyWaycross$55K
- Rishin KadakiaAtlanta$53K
- Javan BassLithonia$43K
- Bhavin MehtaAtlanta$43K
- Corbett ThigpenAugusta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.